Indication

CMV retinitis in AIDS patient

Cytomegalovirus retinitis in an AIDS patient is a sight-threatening opportunistic ocular infection caused by the reactivation of human cytomegalovirus in individuals with advanced acquired immunodeficiency syndrome, classically occurring when CD4+ T-lymphocyte counts drop below 50 cells/µL. Read more about CMV retinitis in AIDS patient

51 drugs 43 manufacturers

Advertisement

Drugs that treat it

Common CMV retinitis in AIDS patient therapies.

Showing 1–9 of 51 drugs

CIDOFOVIR

CMV RETINITIS IN AIDS PATIENT
HERITAGE PHARMA

CIDOFOVIR

ANTIVIRAL - CMV INFECTION·CMV RETINITIS IN AIDS PATIENT
MYLAN INSTITUTI

VALGANCICLOVIR HCL

ANTIVIRAL - CMV INFECTION·CMV RETINITIS IN AIDS PATIENT·+3
DR.REDDY'S LAB
Filter & compare in the drug finder →Opens the drug finder with CMV retinitis in AIDS patient preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About CMV retinitis in AIDS patient.

Cytomegalovirus retinitis in an AIDS patient is a sight-threatening opportunistic ocular infection caused by the reactivation of human cytomegalovirus in individuals with advanced acquired immunodeficiency syndrome, classically occurring when CD4+ T-lymphocyte counts drop below 50 cells/µL.

The condition primarily impacts the retina and posterior segment of the eye through hematogenous viral spread and cell-to-cell transmission.

It is clinically characterized by necrotizing full-thickness retinitis, retinal hemorrhages, perivascular sheathing, and minimal vitreous inflammation, which present with floaters, scotomas, or progressive painless visual field loss that can advance to rhegmatogenous retinal detachment and irreversible blindness if left untreated.

Personalize your experience

Follow CMV retinitis in AIDS patient and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it